Spironolactone is a potassium-sparing diuretic that has become one of the most valuable prescription treatments for hormonal acne, female pattern hair loss, and polycystic ovary syndrome (PCOS). Originally approved for high blood pressure and edema, it is now widely used off-label in dermatology because of its ability to block androgen receptors and reduce androgen production. Generic spironolactone is inexpensive, and Indian manufacturers supply it globally at prices far below US retail. This guide covers how spironolactone works, standard dosing for acne and hair loss, its safety profile, and how to compare costs between generic and brand options.
What Is Spironolactone?
Spironolactone is a synthetic steroidal aldosterone antagonist developed in the 1950s. It works by blocking the mineralocorticoid receptor, which promotes sodium and water excretion while sparing potassium — hence the name “potassium-sparing diuretic.” It also acts as a weak androgen receptor antagonist and inhibits androgen biosynthesis, which is the basis for its dermatologic uses.
The brand name in the US is Aldactone, originally developed by Searle (now part of Pfizer). Generic spironolactone is manufactured worldwide, with major Indian producers including Cipla, Sun Pharma, Intas, and Zydus. Indian generic spironolactone is bioequivalent to the innovator product and is exported to dozens of countries under WHO-GMP certification.
How Spironolactone Works in Acne, Hair Loss, and PCOS
The dermatologic effects of spironolactone come from three complementary mechanisms:
- Androgen receptor blockade — spironolactone competitively blocks dihydrotestosterone (DHT) and testosterone from binding to androgen receptors in sebaceous glands and hair follicles, reducing sebum production and androgen-driven miniaturization of hair.
- Reduced androgen synthesis — it inhibits enzymes involved in ovarian and adrenal androgen production (including CYP17), lowering circulating testosterone in women.
- Increased androgen clearance — at higher doses it modestly increases testosterone metabolism and clearance, further reducing active androgen levels.
In hormonal acne, excess androgens stimulate sebaceous gland activity, leading to oily skin and inflamed lesions. By blocking this signal, spironolactone reduces oiliness and inflammatory lesions, particularly along the jawline and chin. In female pattern hair loss (androgenetic alopecia), androgens miniaturize scalp follicles over time; spironolactone slows or partially reverses this process. In PCOS, where hyperandrogenism drives acne, hirsutism, and hair thinning, spironolactone helps manage the skin and hair manifestations alongside hormonal therapy.
Approved and Common Uses
Spironolactone is FDA-approved for:
- Hypertension (high blood pressure) — usually as part of combination therapy
- Edema (fluid retention) in heart failure, cirrhosis, and nephrotic syndrome
- Primary hyperaldosteronism — diagnosis and long-term management
- Hypokalemia prevention in patients on thiazide or loop diuretics
Common dermatologic and hormonal uses (off-label but guideline-supported):
- Hormonal acne in adult women — recommended in acne guidelines (e.g., American Academy of Dermatology) as first-line hormonal therapy for women who do not respond to topical treatment or oral antibiotics.
- Female pattern hair loss — used in women who cannot use or prefer not to use topical minoxidil, often combined with minoxidil.
- PCOS-related hyperandrogenism — acne, hirsutism (excess facial/body hair), and scalp hair thinning.
- Hirsutism — reduces new hair growth over several months; combined with oral contraceptives for maximal effect.
Dosage and Administration
Spironolactone is available as 25 mg and 100 mg tablets. Dermatologic dosing typically starts low and is titrated upward based on response and tolerance.
| Use | Typical Starting Dose | Maintenance Dose | Time to Benefit |
|---|---|---|---|
| Hormonal acne (women) | 25–50 mg once daily | 50–100 mg/day (sometimes 150–200 mg) | 8–12 weeks for visible improvement |
| Female pattern hair loss | 25–50 mg once daily | 50–100 mg/day | 6–12 months to see regrowth |
| PCOS / hirsutism | 25–50 mg once daily | 50–100 mg/day (combined with OCP) | 3–6 months for hirsutism |
| Hypertension | 25–50 mg/day in 1–2 divided doses | 50–100 mg/day | 2–4 weeks |
| Heart failure (edema) | 12.5–25 mg once daily | 25–50 mg/day (max 100 mg) | Days to weeks |
Key administration points:
- Take spironolactone with food to improve absorption and reduce stomach upset.
- Take the evening dose early enough to avoid nighttime urination — diuretic effect can cause nocturia.
- Do not use potassium supplements or salt substitutes containing potassium while on spironolactone without medical advice.
- Blood tests (potassium, kidney function) should be checked before starting and within 1–2 months, then periodically, especially in older adults or those with kidney disease.
- Improvement in acne typically takes 8–12 weeks; hair regrowth takes 6–12 months. Consistency matters — do not stop early.
- Spironolactone is generally used in women; use in men is limited by feminizing side effects (gynecomastia) except for specific conditions.
Spironolactone vs Other Acne and Hair Loss Treatments
Several oral options exist for hormonal acne and female hair loss. The table below compares them on mechanism, convenience, and typical monthly cost of generic versions.
| Treatment | Mechanism | Main Use | Typical Generic Cost per Month |
|---|---|---|---|
| Spironolactone | Androgen receptor blocker + reduces androgen synthesis | Hormonal acne, female hair loss, PCOS, hirsutism | Low ($3–$12) |
| Oral contraceptive (OCP) | Suppresses ovarian androgens, raises SHBG | Hormonal acne, PCOS, contraception | Low–moderate ($10–$40) |
| Minoxidil (topical/oral) | Hair growth stimulant (vasodilator) | Androgenetic alopecia (men and women) | Low ($5–$20) |
| Finasteride / Dutasteride | 5-alpha reductase inhibitor (blocks DHT) | Male pattern hair loss; occasionally female (off-label) | Low ($3–$15) |
| Isotretinoin | Retinoid, shrinks sebaceous glands | Severe nodular acne | Moderate–high ($50–$150) |
Clinical evidence: Multiple randomized and observational studies support spironolactone for acne. A 2017 systematic review found moderate-to-high quality evidence that spironolactone improves inflammatory acne in adult women. In female pattern hair loss, observational studies show stabilization of shedding and some regrowth in the majority of women who continue treatment for 6–12 months. For hirsutism in PCOS, spironolactone plus an oral contraceptive is more effective than either alone, according to Endocrine Society guidelines.
Spironolactone Generic Pricing: India vs US
Spironolactone is one of the least expensive prescription medications available. Indian generic tablets are dramatically cheaper than US retail prices, making long-term dermatologic therapy (which often runs 6–24 months) far more affordable.
All prices below are approximate ranges for comparison — actual prices vary by pharmacy, pack size, and time. Confirm the current price before ordering.
| Pack | Indian Generic (approx.) | US Generic (approx.) | US Brand Aldactone (approx.) |
|---|---|---|---|
| 30 tablets x 25 mg | $0.7–$1.3 | $4–$10 | $25–$60 |
| 30 tablets x 100 mg | $1.0–$2.2 | $6–$14 | $45–$110 |
| 60 tablets x 25 mg (2-month supply) | $1.3–$2.6 | $8–$20 | $50–$120 |
| 90 tablets x 100 mg (3-month supply) | $2.5–$5.5 | $18–$40 | $135–$330 |
A typical 3-month course of spironolactone 50 mg/day for acne might cost roughly $2–$6 with Indian generics, versus $20–$60 with US generics and $100–$300 for the Aldactone brand. For patients paying out of pocket, that difference can determine whether long-term therapy is feasible. Browse skincare and dermatology treatment options to compare availability and pricing.
Side Effects and Safety Profile
Spironolactone has a well-characterized safety profile, but because it is a diuretic and an anti-androgen, it requires monitoring.
Common side effects
- Hyperkalemia (elevated potassium) — the most clinically important risk, especially in kidney disease or when combined with ACE inhibitors
- Breast tenderness, breast enlargement (gynecomastia) — can occur in women and men
- Menstrual irregularities (spotting, irregular cycles) — common at higher doses
- Dizziness, lightheadedness, or low blood pressure — especially when starting
- Increased urination and nocturia
- Fatigue, headache, or gastrointestinal upset
Serious side effects (rare)
- Severe hyperkalemia — can cause dangerous heart rhythm disturbances; more likely in older patients, kidney disease, or with potassium-sparing combinations
- Acute kidney injury — usually in dehydrated or renally impaired patients
- Allergic reactions — rash, angioedema, anaphylaxis (rare)
- Blood dyscrasias — agranulocytosis or thrombocytopenia (very rare)
- Liver dysfunction — rare, generally reversible
Long-term safety: Spironolactone is not approved for acne in the US but has been used off-label for decades with a strong real-world safety record. The drug has a boxed warning about tumorigenicity based on chronic high-dose animal studies (50–500 mg/kg/day) — doses far above human use — but epidemiological data have not shown a meaningful cancer signal in humans at therapeutic doses. As with any chronic medication, routine follow-up with your prescriber is essential.
Pregnancy: Spironolactone is contraindicated in pregnancy because of anti-androgenic effects on fetal development (FDA Category C; animal data show feminization of male fetuses). Women of reproductive age should use reliable contraception and stop the drug before attempting pregnancy. It is generally avoided during breastfeeding because the active metabolite (canrenone) passes into breast milk.
Who Should Not Take Spironolactone?
- Pregnant women or women planning pregnancy
- Patients with severe kidney impairment or anuria
- Patients with hyperkalemia (elevated potassium)
- Patients with Addison disease (adrenal insufficiency)
- Patients taking eplerenone or other potassium-sparing agents without close monitoring
- Men — only rarely, because of gynecomastia and reduced libido, unless the benefit clearly outweighs the risk
Monitoring While on Spironolactone
- Serum potassium and creatinine at baseline, 1–2 months after starting or after a dose increase, and then every 3–6 months
- Blood pressure checks, especially in the first weeks
- Review of menstrual pattern and breast symptoms at follow-up visits
- If you start an ACE inhibitor, ARB, or potassium supplement, potassium must be rechecked
- Avoid over-the-counter potassium supplements and salt substitutes with potassium chloride
Frequently Asked Questions
1. How long does spironolactone take to clear acne?
Most women see noticeable improvement in inflammatory acne after 8–12 weeks at an adequate dose (50–100 mg/day). Full benefit may take 3–6 months. If there is no improvement after 3–4 months, your prescriber may increase the dose or add another treatment.
2. Does spironolactone cause weight gain or weight loss?
Spironolactone causes fluid loss initially, which can produce a small, temporary weight decrease. It does not typically cause significant weight gain. Some women report breast fullness and bloating, which are fluid and hormonal effects rather than true weight gain.
3. Can men take spironolactone?
Spironolactone is rarely used in men because it frequently causes breast enlargement (gynecomastia), reduced libido, and erectile dysfunction. Its main uses in men are for heart failure, hypertension, and cirrhosis-related edema, where the benefits outweigh these effects.
4. Is spironolactone safe to take long-term?
Yes, with appropriate monitoring. Many women take spironolactone for years for acne or hair loss. The key is periodic blood tests for potassium and kidney function, and avoiding pregnancy while on the drug. It is not a cure — acne and hair loss typically return if the drug is stopped.
5. Can I take spironolactone with birth control pills?
Yes, this is a very common and effective combination. Oral contraceptives suppress ovarian androgen production and raise sex hormone-binding globulin, complementing the effects of spironolactone. The combination is especially useful for PCOS and also ensures reliable contraception, which is essential because spironolactone is not safe in pregnancy.
6. What happens if I stop spironolactone?
Acne and hair loss symptoms typically return within 3–6 months of stopping, because the underlying androgen sensitivity remains. Most dermatologists recommend continuing maintenance therapy for as long as the condition is active.
Bottom Line
Spironolactone is a safe, effective, and inexpensive treatment for hormonal acne, female pattern hair loss, and PCOS-related symptoms when used under medical supervision. Its greatest practical barrier for many patients is not efficacy but the cost of brand-name therapy — a barrier that Indian generic spironolactone removes entirely. With monthly costs in the range of a few dollars, long-term dermatologic treatment becomes realistic for out-of-pocket patients. Review your options on our skincare treatment category page and always discuss dosing and monitoring with a qualified healthcare provider.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. Pricing information reflects approximate market ranges and varies by pharmacy, location, and time; always confirm current prices with your supplier. Generic medications should only be used under professional supervision.
References
- Spironolactone FDA Prescribing Information (Aldactone label), US FDA.
- Zaenglein AL, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973 (American Academy of Dermatology).
- Martin KA, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(4):1233-1257.
- van Zuuren EJ, et al. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016.
- Layton AM, et al. A review of the use of spironolactone in dermatology. Clin Exp Dermatol. 2017;42(4):373-378.
- UpToDate. Spironolactone: Drug information. Wolters Kluwer.
